Latest news with #proof-of-concept
Business Times
4 days ago
- Business
- Business Times
Singapore SMEs can tap Japanese technology for innovative solutions
[SINGAPORE] Small and medium-sized enterprises (SMEs) can work with Japanese giants to find applications for innovative technology or develop new solutions together, under an initiative that is now in its second year. The second Japanese Corporates Technology Innovation (JCTI) Launchpad networking event on Thursday (May 29) featured six Japanese multinational corporations (MNCs) – one more than the inaugural event in 2024. Returning for a second year are electronics manufacturers Ricoh, Panasonic and Nisshinbo; Mitsui Chemicals; and packaging maker Toyo Seikan Group. They are joined by adhesive maker Nitto Denko, which is seeking partners for a stress-monitoring smart watch. Nitto Denko was one of four participants showcasing 'co-development-ready' technology and intellectual property (IP) – innovations that have been developed but need to be tested or applied. The companies are therefore seeking Singapore SMEs as proof-of-concept partners. A NEWSLETTER FOR YOU Friday, 8.30 am SGSME Get updates on Singapore's SME community, along with profiles, news and tips. Sign Up Sign Up Nisshinbo and Toyo Seikan did not give details of specific technologies, but attended to network with local SMEs and seek potential partnerships. Since the JCTI Launchpad began last year, eight projects have been formed across sectors such as sustainability, chemicals and communications. Matching innovation and application The JCTI Launchpad event this year is organised by Enterprise Singapore subsidiary Innovation Partner for Impact (IPI), the Japan External Trade Organization (Jetro) and business consulting firm N9. It aims to match advanced technologies from Japan with Singapore companies who can put them to good use. In a media release, the organisers noted that Japan has a wealth of IP, yet many corporate technologies are underutilised – while Singaporean companies and startups are looking for unique technologies but face challenges in adapting and accessing them. Under the JCTI Launchpad, Singapore SMEs can license or source technology from the MNCs, or work together to co-develop solutions. 'It is heartening that our Japanese partners are generous with sharing their technologies and know-how with our local SMEs,' said IPI chief operating officer Michael Goh. 'The beauty of working with diverse corporations across different industries is the diverse types of technologies our SMEs can access,' he added. IPI helps local SMEs collaborate with technology providers, research institutions, and other companies. For example, local water treatment supplier Bioflux is partnering Panasonic to develop a coating that prevents algae and scale from forming on cooling towers and chillers. Bioflux managing director Michael Ng said: 'As Panasonic is a huge company, we hope this collaboration will allow us to work more closely with them and develop better water treatment services for Singapore.' Nitto Denko's senior business development manager Sugihara Takaya noted that the technology in Singapore 'is more mature and comfortable to work with', adding: 'We hope that Singapore can be a stepping stone for us to reach out to other regions in the future.' The company has embedded optical sensors and 3-axis acceleration sensors into a wristwatch, allowing it to track the wearer's stress level. It is looking for partners that can either diversify the type of wearable devices using this technology; diversify algorithms to enhance the application of data; or expand business channels in healthcare across Asia, the US and Europe.
Yahoo
26-03-2025
- Business
- Yahoo
Asgard Therapeutics appoints immunology expert Shane Olwill as Chief Development Officer
Pioneering cancer immunology company Asgard strengthens leadership team as it progresses its lead asset AT-108 towards clinical trials Shane brings over two decades of expertise in immunology-driven drug discovery with a specialized focus on novel modalities AT-108 is a first-in-class, off-the-shelf cell reprogramming therapy that leads to personalized and potent anti-cancer immune responses LUND, Sweden, March 26, 2025 /PRNewswire/ -- Asgard Therapeutics, a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy, today announces the appointment of experienced immunology drug development specialist Shane Olwill as Chief Development Officer (CDO). Shane, who joins Asgard from Pieris Pharmaceuticals, now merged with NASDAQ-listed Palvella Therapeutics, will lead IND-enabling studies and clinical trials planning for Asgard's lead asset AT-108. AT-108 is a first-in-class, off-the-shelf cell reprogramming therapy that forces tumor cells to present their own tumor antigens, inducing a personalized immune response tailored to target each patient's cancer. Last September, Asgard had a key paper published in the high-impact journal Science which provided strong in vivo pre-clinical proof-of-concept for AT-108. During his thirteen years at Pieris, Shane played a pivotal role developing its diverse pipeline of clinical programs in immuno-oncology and respiratory diseases – progressing nine programs into the clinic. Prior to that he was Director of Research at AIM-listed Fusion Antibodies, building out its research team and establishing its technology platform. With over 60 intellectual property rights to his name, he is a recognized leader in drug development and a regular reviewer for prominent oncology and drug development journals. He holds a BSc in Biomedical Sciences and a PhD in Molecular Hematology from the University of Ulster, UK. Cristiana Pires, Co-founder and Chief Executive Officer of Asgard Therapeutics, said: "I'm delighted to welcome Shane as Asgard's CDO at this exciting time, as we progress our lead product AT-108 towards clinical trials and transition to a drug development company. Shane's skill set, derived from his extensive experience of pipeline development, particularly in immuno-oncology, is highly complementary to the other members of our team and will be of great benefit as we move forwards." Shane Olwill, Chief Development Officer of Asgard Therapeutics, said: "Asgard's in vivo cell reprogramming technology, based on the deep research and understanding of its founders, is a potentially transformative new form of cancer immunotherapy that is not only powerful but also indication-agnostic. I'm delighted to be joining the Company, whose science is backed by very strong data and whose team is supported by high calibre investors. I look forward to working to progress AT-108 towards the clinic and maximizing the potential of Asgard's wider platform." Martin Bonde, Chair of Asgard Therapeutics, said: "Shane will be instrumental as we further progress IND-enabling studies and CMC development for AT-108, to facilitate a seamless transition of the program to the clinic." Notes to Editors About Asgard Therapeutics Asgard Therapeutics is a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy. The company builds on ground-breaking and proprietary reprogramming technologies to develop gene therapy products designed to set in motion efficient and personalized immune responses. Backed by Johnson & Johnson Innovation – JJDC, Inc., RV Invest, Novo Holdings, Boehringer Ingelheim Venture Fund, and Industrifonden, Asgard Therapeutics aims to establish a pipeline of off-the shelf cancer immunotherapies that trigger personalized anti-cancer immune responses for the benefit of cancer patients in need. For more information, please visit: About AT-108 AT-108 is a first-in-class, off-the-shelf gene therapy that directly reprograms tumor cells into a rare subset of dendritic cells critical for mounting efficient cytotoxic T cell responses, cDC1 cells (conventional dendritic cells type 1). Reprogramming forces the tumor cells to present their tumor antigens, ultimately leading to a personalized anti-tumor immune response. It is based on a replication-deficient adenoviral vector that delivers three proprietary reprogramming factors into tumor cells, rewiring their gene expression signatures and thus "programming" them to become antigen-presenting cDC1-like cells. View original content: SOURCE Asgard Therapeutics
ARN News Center
11-03-2025
- Business
- ARN News Center
ADNOC, AIQ sign $340M deal to deploy AI across upstream operations
ADNOC and AIQ, a Presight company, have signed an agreement worth $340 million (AED 1.2 trillion) to deploy ENERGYai and associated AI solutions across ADNOC's upstream value chain. The three-year contract will see ENERGYai and a suite of related AI solutions rolled out across ADNOC's upstream operations, driving optimisation and efficiency. ENERGYai combines large language model (LLM) technology with cutting-edge agentic AI, which is trained for specific workflows across ADNOC's upstream value chain. ENERGYai will use large language models to enable engineers to 'talk' to ADNOC's proprietary data, maximising individual productivity, delivering new insights and opportunities. The Acting Managing Director of AIQ, Magzhan Kenesbai, said, 'This contract marks a defining moment for AIQ. In partnership with ADNOC, we have developed a world-first agentic AI solution that is scalable across the entire energy value chain and has the potential to transform the industry as we know it. "We are proud to see ENERGYai move from a successful proof-of-concept to full deployment, enabling ADNOC to unlock unparalleled efficiencies, reduce carbon intensity, and advance their sustainability ambitions. This achievement reflects our commitment to delivering innovative, high-impact AI solutions that not only meet the challenges of today but also shape the future of energy.' Developed by AIQ with ADNOC experts, in collaboration with G42 and Microsoft, ENERGYai will integrate best-in-class technologies, including Azure cloud stack, agentic AI platform functionality, Open Subsurface Data Universe framework (OSDU), and OpenAI models. The CEO of Presight, Thomas Pramotedham, said, 'We congratulate AIQ on signing the agreement with ADNOC. As the major shareholder of AIQ, we are incredibly proud to see this partnership come to life, and we remain committed to supporting AIQ's growth as it continues to drive innovation and create lasting value for the energy industry and our shareholders. "Agentic AI is widely recognised by experts as the future of AI development and integration. Here in the UAE, through Presight's collaboration with AIQ and ADNOC, we are not just predicting the future, we are creating it with applied intelligence today. ENERGYai is a world-leading solution that will set the benchmark for innovation and excellence in agentic AI." The first operational, scalable version of ENERGYai is expected to be completed in mid-2025. This version will include five fully operational AI agents covering tasks within subsurface operations and will be test-deployed across several upstream assets, with plans to scale its application to thousands of additional wells. Over the three-year contract term, AIQ will complete the roll out of ENERGYai to all ADNOC's upstream assets, comprising more than 28 producing fields, including some of the world's largest and least carbon intensive oilfields.
Dubai Eye
11-03-2025
- Business
- Dubai Eye
ADNOC, AIQ sign $340M deal to deploy AI across upstream operations
ADNOC and AIQ, a Presight company, have signed an agreement worth $340 million (AED 1.2 trillion) to deploy ENERGYai and associated AI solutions across ADNOC's upstream value chain. The three-year contract will see ENERGYai and a suite of related AI solutions rolled out across ADNOC's upstream operations, driving optimisation and efficiency. ENERGYai combines large language model (LLM) technology with cutting-edge agentic AI, which is trained for specific workflows across ADNOC's upstream value chain. ENERGYai will use large language models to enable engineers to 'talk' to ADNOC's proprietary data, maximising individual productivity, delivering new insights and opportunities. The Acting Managing Director of AIQ, Magzhan Kenesbai, said, 'This contract marks a defining moment for AIQ. In partnership with ADNOC, we have developed a world-first agentic AI solution that is scalable across the entire energy value chain and has the potential to transform the industry as we know it. "We are proud to see ENERGYai move from a successful proof-of-concept to full deployment, enabling ADNOC to unlock unparalleled efficiencies, reduce carbon intensity, and advance their sustainability ambitions. This achievement reflects our commitment to delivering innovative, high-impact AI solutions that not only meet the challenges of today but also shape the future of energy.' Developed by AIQ with ADNOC experts, in collaboration with G42 and Microsoft, ENERGYai will integrate best-in-class technologies, including Azure cloud stack, agentic AI platform functionality, Open Subsurface Data Universe framework (OSDU), and OpenAI models. The CEO of Presight, Thomas Pramotedham, said, 'We congratulate AIQ on signing the agreement with ADNOC. As the major shareholder of AIQ, we are incredibly proud to see this partnership come to life, and we remain committed to supporting AIQ's growth as it continues to drive innovation and create lasting value for the energy industry and our shareholders. "Agentic AI is widely recognised by experts as the future of AI development and integration. Here in the UAE, through Presight's collaboration with AIQ and ADNOC, we are not just predicting the future, we are creating it with applied intelligence today. ENERGYai is a world-leading solution that will set the benchmark for innovation and excellence in agentic AI." The first operational, scalable version of ENERGYai is expected to be completed in mid-2025. This version will include five fully operational AI agents covering tasks within subsurface operations and will be test-deployed across several upstream assets, with plans to scale its application to thousands of additional wells. Over the three-year contract term, AIQ will complete the roll out of ENERGYai to all ADNOC's upstream assets, comprising more than 28 producing fields, including some of the world's largest and least carbon intensive oilfields.
Gulf Business
11-03-2025
- Business
- Gulf Business
AIQ secures $340m contract to deploy agentic AI across ADNOC ops
Image: Supplied AIQ, a subsidiary of Presight, has secured a $340m contract from Abu Dhabi National Oil Company (ADNOC) to deploy its ENERGYai platform and associated AI solutions across ADNOC's upstream operations, marking one of the largest applications of agentic AI in the energy sector. The three-year contract follows the successful completion of a proof-of-concept phase and will see AIQ roll out ENERGYai to optimise ADNOC's upstream processes. The platform integrates large language models (LLM) with advanced agentic AI, enabling workflow automation across the company's upstream value chain, from seismic analysis to real-time process monitoring. Advancing ADNOC's AI strategy Musabbeh Al Kaabi, ADNOC's Upstream CEO, said the initiative aligns with the company's ambition to become the world's most AI-enabled energy firm. 'We look forward to working with AIQ to scale ENERGYai across our upstream business, consolidating our position as a responsible and reliable supplier of energy to global markets,' he said in a statement. ENERGYai allows engineers to interact with ADNOC's proprietary data using LLMs, enhancing efficiency and providing new insights. By accelerating processes and reducing operational costs, the AI-driven system is expected to contribute to ADNOC's broader digital transformation and sustainability goals. A milestone for AIQ Magzhan Kenesbai, acting MD of AIQ, described the contract as a 'defining moment' for the company. 'In partnership with ADNOC, we have developed a world-first agentic AI solution that is scalable across the energy value chain and has the potential to transform the industry. This deployment will unlock unparalleled efficiencies and support ADNOC's sustainability ambitions,' he said. Developed with input from ADNOC experts and in collaboration with G42 and Microsoft, ENERGYai leverages Azure cloud infrastructure, the Open Subsurface Data Universe (OSDU) framework, and OpenAI models. Thomas Pramotedham, CEO of Presight, The first operational version of ENERGYai is expected by mid-2025, initially covering five AI agents for subsurface operations. It will be test-deployed across several ADNOC upstream assets before expanding to more than 28 producing fields, including some of the world's largest and lowest-carbon oilfields. Read:
